REFERENCES IN TABLE 1
1. Aagard K, Luna RA, Versalovic J. The Human Microbiome of Local Body sites and Their
Unique Biology. In: Mandell, Douglas, and Bennett's principles and practice of infectious
diseases. Elsevier Health Sciences, 2014:11–18.
2. Sinner SW. Viridans Streptococci, Nutritionally Variant Streptococci, Groups C and G
Streptococci, and Other Related Organisms. In: Mandell, Douglas, and Bennett's principles and
practice of infectious diseases. Elsevier Health Sciences, 2014:2349–2361.
3. Human Microbiome Project Consortium. Structure, function and diversity of the healthy
human microbiome. Nature 2012;486:207–214.
4. Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human
periodontal pocket and other oral sites. Periodontol. 2000 2006;42:80–87.
5. Curtis MA, Zenobia C, Darveau RP. The relationship of the oral microbiotia to periodontal
health and disease. Cell Host Microbe 2011;10:302–306.
6. Frandsen EV, Pedrazzoli V, Kilian M. Ecology of viridans streptococci in the oral cavity and
pharynx. Oral Microbiol. Immunol. 1991;6:129–133.
7. Fowler VG, Scheld MW, Bayer AS. Endocarditis and Intravscular Infections. In: Mandell,
Douglas, and Bennett's principles and practice of infectious diseases. Elsevier Health Sciences,
2014:990–1028.
8. Corredoira J, Alonso MP, Coira A, et al. Characteristics of Streptococcus bovis endocarditis
and its differences with Streptococcus viridans endocarditis. Eur. J. Clin. Microbiol. Infect. Dis.
2008;27:285–291.
9. Tomás Carmona I, Diz Dios P, Limeres Posse J, González Quintela A, Martínez Vázquez C,
Castro Iglesias A. An update on infective endocarditis of dental origin. J Dent 2002;30:37–40.
10. Petti CA, Straton CW. Streptococcus anginosus Group. In: Mandell, Douglas, and Bennett's
principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2362–2365.
11. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev. Infect.
Dis. 1988;10:257–285.
12. Coykendall AL. Classification and identification of the viridans streptococci. Clin.
Microbiol. Rev. 1989;2:315–328.
13. Belko J, Goldmann DA, Macone A, Zaidi AK. Clinically significant infections with
organisms of the Streptococcus milleri group. Pediatr. Infect. Dis. J. 2002;21:715–723.
14. Cunha BA, D'Elia AA, Pawar N, Schoch P. Viridans streptococcal (Streptococcus
intermedius) mitral valve subacute bacterial endocarditis (SBE) in a patient with mitral valve
prolapse after a dental procedure: the importance of antibiotic prophylaxis. Heart Lung
2010;39:64–72.
15. Arias CA, Murray BE. Enterococcus Species, Streptococcus gallolyticus Group, and
Leuconostoc Species. In: Mandell, Douglas, and Bennett's principles and practice of infectious
diseases. Elsevier Health Sciences, 2014:2328–2339.
16. Boleij A, Tjalsma H. The itinerary of Streptococcus gallolyticus infection in patients with
colonic malignant disease. Lancet Infect Dis 2013;13:719–724.
17. Boleij A, van Gelder MMHJ, Swinkels DW, Tjalsma H. Clinical Importance of
Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and
meta-analysis. Clin. Infect. Dis. 2011;53:870–878.
18. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's principles and practice of
infectious diseases. Elsevier Health Sciences; 2014.
19. Schlegel L, Grimont F, Ageron E, Grimont PAD, Bouvet A. Reappraisal of the taxonomy of
the Streptococcus bovis/Streptococcus equinus complex and related species: description of
Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus
subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. International Journal of
Systematic and Evolutionary Microbiology 2003;53:631–645.
20. Corredoira-Sánchez J, García-Garrote F, Rabuñal R, et al. Association between bacteremia
due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal
neoplasia: a case-control study. Clin. Infect. Dis. 2012;55:491–496.
21. Fernández Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, de Górgolas M.
Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic
factors with emphasis on hospital-acquired infections as a major determinant of outcome.
Medicine 2007;86:363–377.
22. Edwards MS, Baker CJ. Streptococcus agalactiae (Group B Streptococcus). In: Mandell,
Douglas, and Bennett's principles and practice of infectious diseases. Elsevier Health Sciences,
2014:2340–2349.
23. Sambola A, Miro JM, Tornos MP, et al. Streptococcus agalactiae infective endocarditis:
analysis of 30 cases and review of the literature, 1962-1998. Clin. Infect. Dis. 2002;34:1576–
1584.
24. Smyth EG, Pallett AP, Davidson RN. Group G streptococcal endocarditis: two case reports, a
review of the literature and recommendations for treatment. J. Infect. 1988;16:169–176.
25. Bradley SF, Gordon JJ, Baumgartner DD, Marasco WA, Kauffman CA. Group C
streptococcal bacteremia: analysis of 88 cases. Rev. Infect. Dis. 1991;13:270–280.
26. Bryant AE, Stevens DL. Streptococcus pyogenes. In: Mandell, Douglas, and Bennett's
principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2285–2299.
27. Ramirez CA, Naraqi S, McCulley DJ. Group A beta-hemolytic streptococcus endocarditis.
Am. Heart J. 1984;108:1383–1386.
28. Janoff EN, Musher DM. Streptococcus pneumoniae. In: Mandell, Douglas, and Bennett's
principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2310–2327.
29. Bruyn GA, Thompson J, Van der Meer JW. Pneumococcal endocarditis in adult patients. A
report of five cases and review of the literature. Q. J. Med. 1990;74:33–40.
30. Takeshita T, Yasui M, Shibata Y, et al. Dental plaque development on a hydroxyapatite disk
in young adults observed by using a barcoded pyrosequencing approach. Sci Rep 2015;5:8136.
31. Ramos JN, Santos dos LS, Vidal LMR, et al. A case report and literature overview:
Abiotrophia defectiva aortic valve endocarditis in developing countries. Infection 2014;42:579–
584.
32. Adam EL, Siciliano RF, Gualandro DM, et al. Case series of infective endocarditis caused by
Granulicatella species. Int. J. Infect. Dis. 2015;31:56–58.
33. Centers for Disease Control and Prevention (CDC). Fatal rat-bite fever--Florida and
Washington, 2003. MMWR Morb. Mortal. Wkly. Rep. 2005;53:1198–1202.
34. Kimura M, Tanikawa T, Suzuki M, et al. Detection of Streptobacillus spp. in feral rats by
specific polymerase chain reaction. Microbiol. Immunol. 2008;52:9–15.
35. Madhubashini M, George S, Chandrasekaran S. Streptobacillus moniliformis endocarditis:
case report and review of literature. Indian Heart J 2013;65:442–446.
36. Rupp ME. Streptobacillus moniliformis endocarditis: case report and review. Clin. Infect.
Dis. 1992;14:769–772.
37. Wertheim H FL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al.
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;12:751762.
38. Que Y-A, Moreillon P. Staphylococcus aureus (Including Staphylococcal Toxic Shock
Syndrome). In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases.
Elsevier Health Sciences, 2014:2237–2271.
39. Saginur R, Suh KN. Staphylococcus aureus bacteraemia of unknown primary source: where
do we stand? Int. J. Antimicrob. Agents 2008;32 Suppl 1:S21–5.
40. Bahrain M, Vasiliades M, Wolff M, Younus F. Five cases of bacterial endocarditis after
furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus
aureus infections. Scand. J. Infect. Dis. 2006;38:702–707.
41. Murray RJ. Staphylococcus aureus infective endocarditis: diagnosis and management
guidelines. Intern Med J 2005;35 Suppl 2:S25–44.
42. Rupp ME, Soper DE, Archer GL. Colonization of the female genital tract with
Staphylococcus saprophyticus. J Clin Microbiol 1992;30:2975–2979.
43. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections:
epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015;13:269–
284.
44. Rupp ME, Fey PD. Staphylococcus epidermidis and Other Coagulase-Negative
Staphylococci. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases.
Elsevier Health Sciences, 2014:2Z72–2282.
45. Steinberg JP, Burd EM. Other Gram-Negative and Gram-Variable Bacilli. In: Mandell,
Douglas, and Bennett's principles and practice of infectious diseases. Elsevier Health Sciences,
2014:2666–2683.
46. Patrick WD, Brown WD, Ian Bowmer M, Sinave CP. Infective endocarditis due to Eikenella
corrodens: Case report and review of the literature. Can J Infect Dis 1990;1:139–142.
47. Sheng WS, Hsueh PR, Hung CC, Teng LJ, Chen YC, Luh KT. Clinical features of patients
with invasive Eikenella corrodens infections and microbiological characteristics of the causative
isolates. Eur. J. Clin. Microbiol. Infect. Dis. 2001;20:231–236.
48. Nwaohiri N, Urban C, Gluck J, Ahluwalia M, Wehbeh W. Tricuspid valve endocarditis
caused by Haemophilus parainfluenzae: a case report and review of the literature. Diagn.
Microbiol. Infect. Dis. 2009;64:216–219.
49. Feder HM, Roberts JC, Salazar JC, Leopold HB, Toro-Salazar O. HACEK endocarditis in
infants and children: two cases and a literature review. Pediatr. Infect. Dis. J. 2003;22:557–562.
50. Henderson B, Wilson M, Sharp L, Ward JM. Actinobacillus actinomycetemcomitans. J. Med.
Microbiol. 2002;51:1013–1020.
51. Yew HS, Chambers ST, Roberts SA, et al. Association between HACEK bacteraemia and
endocarditis. J. Med. Microbiol. 2014;63:892–895.
52. Marrie TJ, Raoult D. Coxiella burnetii (Q Fever). In: Mandell, Douglas, and Bennett's
principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2208–2216.
53. Raoult D, Marrie T. Q fever. Clin. Infect. Dis. 1995;20:489–95– quiz 496.
54. Gandhi TN, Welch DF, Koehler JE. Bartonella, Including Cat-Scratch Disease. In: Mandell,
Douglas, and Bennett's principles and practice of infectious diseases. Elsevier Health Sciences,
2014:2649–2643.
55. Mosbacher ME, Klotz S, Klotz J, Pinnas JL. Bartonella henselae and the potential for
arthropod vector-borne transmission. Vector Borne Zoonotic Dis. 2011;11:471–477.
56. Desenclos JC, Laporte A, Brouqui P. [Louse-borne infections in humans]. Med Mal Infect
2011;41:295–300.
57. Marth T, Schneider T. Whipple's Disease. In: Mandell, Douglas, and Bennett's principles and
practice of infectious diseases. Elsevier Health Sciences, 2014:2418–2424.
58. Fenollar F, Lagier J-C, Raoult D. Tropheryma whipplei and Whipple's disease. J. Infect.
2014;69:103–112.
59. Fenollar F, Celard M, Lagier J-C, Lepidi H, Fournier P-E, Raoult D. Tropheryma whipplei
endocarditis. Emerging Infect. Dis. 2013;19:1721–1730.
60. Edelstein PH, Roy CR. Legionnaires' disease and Pontiac Fever. In: Mandell, Douglas, and
Bennett's principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2633–
2644.
61. Gul CH, Erdem H. Brucellosis (Brucella Species). In: Mandell, Douglas, and Bennett's
principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2584–2589.
62. Branger S, Casalta JP, Habib G, Collard F, Raoult D. Escherichia coli endocarditis: seven
new cases in adults and review of the literature. Eur. J. Clin. Microbiol. Infect. Dis.
2005;24:537–541.
63. Kim R, Reboli AC. Other Coryneform Bacteria and Rhodococci. In: Mandell, Douglas, and
Bennett's principles and practice of infectious diseases. Elsevier Health Sciences, 2014:2373–
2382.
64. D'Agata E. Pseudomonas aeruginosa and Other Pseudomonas Species. In: Mandell, Douglas,
and Bennett's principles and practice of infectious diseases. Elsevier Health Sciences,
2014:2518–2531.
65. Dawson NL, Brumble LM, Pritt BS, Yao JD, Echols JD, Alvarez S. Left-sided Pseudomonas
aeruginosa endocarditis in patients without injection drug use. Medicine 2011;90:250–255.
66. Minces LR, Shields RK, Sheridan K, Ho KS, Silveira FP. Peptostreptococcus infective
endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the
literature. Anaerobe 2010;16:327–330.
67. Marín A, Lustig N, Cruz R, Córdova S. [Infective endocarditis caused by Listeria
monocytogenes: review of the literature and a case report]. Rev Chilena Infectol 2013;30:436–
440.
68. Sohail MR, Gray AL, Baddour LM, Tleyjeh IM, Virk A. Infective endocarditis due to
Propionibacterium species. Clin. Microbiol. Infect. 2009;15:387–394.
69. Kurz M, Kaufmann BA, Baddour LM, Widmer AF. Propionibacterium acnes prosthetic
valve endocarditis with abscess formation: a case report. BMC Infect. Dis. 2014;14:105.
70. Kalokhe AS, Rouphael N, Chami El MF, Workowski KA, Ganesh G, Jacob JT. Aspergillus
endocarditis: a review of the literature. Int. J. Infect. Dis. 2010;14:e1040–7.
71. Bush LM, Paturi A, Chaparro-Rojas F, Perez MT. Mycobacterial prosthetic valve
endocarditis. Curr Infect Dis Rep 2010;12:257–265.
72. Bouchiat C, Saison J, Boisset S, et al. Nontuberculous Mycobacteria: An Underestimated
Cause of Bioprosthetic Valve Infective Endocarditis. Open Forum Infect Dis 2015;2:ofv047.
73. Yuan S-M. Mycobacterial endocarditis: a comprehensive review. Rev Bras Cir Cardiovasc
2015;30:93–103.
74. Sax H, Bloemberg G, Hasse B, et al. Prolonged Outbreak of Mycobacterium chimaera
Infection After Open-Chest Heart Surgery. Clin Infect Dis 2015;61:67–75.
75. Lefort A, Chartier L, Sendid B, et al. Diagnosis, management and outcome of Candida
endocarditis. Clin. Microbiol. Infect. 2012;18:E99–E109.